Get started
Author

Joseph T. Duffy

Observed names: J. T. Duffy, J.T. Duffy, Joseph Duffy, Joseph T Duffy
ORCID: 0000-0002-7895-3966
Observed ORCID: 0000-0002-7895-3966
OpenAlex ID: A5061492472
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
2023 · Markella Zannikou, Joseph T Duffy, et al. · Journal for ImmunoTherapy of Cancer · 92
PDF
Modeling glioblastoma complexity with organoids for personalized treatments
2023 · Kristen D. Pawlowski, Joseph T. Duffy, et al. · Trends in Molecular Medicine · 38
Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors
2022 · Irina V. Balyasnikova, Markella Zannikou, et al. · Journal of Controlled Release · 18
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
2023 · Kristen D. Pawlowski, Joseph T. Duffy, et al. · Cancers · 17
PDF
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases
2023 · Jawad Fares, Edgar Petrosyan, et al. · Journal of Clinical Investigation · 17
Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas
2023 · Kristen D. Pawlowski, Joseph T. Duffy, et al. · Cells · 10
PDF
Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment
2023 · Edgar Petrosyan, Jawad Fares, et al. · Molecular Cancer Research · 8
PDF
MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, microglia phenotype, and immune checkpoint blockade efficacy
2024 · Kwang-Soo Kim, Junyi Zhang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7
IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas
2025 · M. Seblani, M. Zannikou, et al. · Acta Neuropathologica Communications · 6
PDF
Microglial fructose metabolism is essential for glioblastoma growth
2026 · Leah K. Billingham, Susan L. DeLay, et al. · Proceedings of the National Academy of Sciences · 5
Bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodeling in immune-competent preclinical models
2025 · Markella Zannikou, Joseph T Duffy, et al. · Journal for ImmunoTherapy of Cancer · 4
Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell–Engaging Antibody in GBM via Passive and Active Mechanisms
2025 · Yutian Feng, Benedikt Haupt, et al. · Clinical Cancer Research · 4
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin
2023 · Jiyong Liang, Dexing Fang, et al. · Cancers · 4
PDF
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors
2026 · Joseph T. Duffy, Angela Martin‐Regalado, et al. · Advanced Science · 3
Role of Serum Stability and Lipoprotein Interactions in Lipid Structure–Tumor Accumulation Relationship
2025 · Ashlynn Barnes, Hanmant K. Gaikwad, et al. · ACS Nano · 2
Targeting CHEK2-YBX1&YBX3 regulatory hub to potentiate immune checkpoint blockade response in gliomas
2025 · Heba Ali, Ningjia Zhou, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
A New Mouse Model of Diffuse Midline Glioma to Test Targeted Immunotherapies
2021 · M Seblani, M Zannikou, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
THOC1 complexes with SIN3A to regulate R-loops and promote glioblastoma progression
2026 · Shreya Budhiraja, Umme H. Faisal, et al. · Neoplasia · 1
EXTH-135. Intrathecally delivered T cells precomplexed with a Bispecific T-cell Engager target CNS tumors
2025 · Benedikt E Haupt, Manuel Fierro Cota, et al. · Neuro-Oncology · 1
PDF
IMMU-73. A Novel Tri-Specific T Cell Engager Improves In Vivo Outcomes by Addressing Glioblastoma Heterogeneity
2025 · Angela Martin-Regalado, Joseph T Duffy, et al. · Neuro-Oncology · 1
PDF
Csig-25. Mapk/erk Signaling in Gliomas Modulates Interferon Responses, Promotes Tumor-microglia Crosstalk, and Confers Susceptibility to Anti-pd-1 and Anti-ctla-4 Immunotherapy
2024 · Kwang-Soo Kim, Junyi Zhang, et al. · Neuro-Oncology · 1
PDF
Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors
2026 · Joseph T Duffy, Irina V Balyasnikova
TMIC-82. Sequestration of inflammatory lipids as an immune evasion mechanism in glioblastoma
2025 · Tzu-Yi Chia, Chao Wei, et al. · Neuro-Oncology
PDF
DDDR-70. Unlocking the Genetic Code of Chemotherapy Response in Glioblastoma
2025 · Lara Koutah, Shengin Liu, et al. · Neuro-Oncology
PDF
Data from Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell–Engaging Antibody in GBM via Passive and Active Mechanisms
2025 · Yutian Feng, Benedikt Haupt, et al.
Works count: 29
Citation count: 243
H-index: 7
I10-index: 6
Year
Topic
Type